Published 20:07 IST, December 2nd 2020
As UK approves Pfizer-BioNtech's COVID-19 vaccine, here's who will get vaccinated first
With British administration aiming to roll out COVID-19 vaccines as early as next week, officials have unveiled their priority list for its distribution.
Advertisement
With British ministration aiming to roll out COVID-19 vaccines as early as next week, officials have unveiled ir priority list for first phase of its distribution. According to a press release, care home residents and ir carers would be a topmost priority to receive vaccine shots followed by elderly and frontline workers. Two groups, which would t recive Pfizer-BioNtech COVID-19 vaccine would include children below of 16 and pregnant women, owing to health risks.
Advertisement
Priority list for Vaccine distribution, Credits: assets.publishing.service.gov.uk
According to Joint Committee on Vaccination and Immunisation, vaccine won’t be “generally available for children.” Clarifying reason for exception, committee explained that most children have mild and asymptomatic disease. “However it will be available for "those children at very high risk of exposure and serious outcomes, such as older children with severe neuro-disabilities that require residential care,” committee explained.
Advertisement
UK approves Pfizer-BioNtech COVID-19 vaccine
UK on December 2 has become first country in world to approve Pfizer-BioNtech COVID-19 vaccine candidate for widespre use. British regulator, MHRA has said that mRNA-based vaccine that has shown 95 per cent efficacy, is safe for mass roll out with immunisations in country starting "early next week" among high priority groups. Britain has reportedly alrey placed an order of 40 million doses of Pfizer-BioNTech's COVID-19 vaccine to provide double-dose immunisation to at least 20 million people.
Advertisement
" Government has today accepted recommendation from independent Medicines and Healthcare products Regulatory ncy (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use. This follows months of rigorous clinical trials and a thorough analysis of data by experts at MHRA who have concluded that vaccine has met its strict standards of safety, quality and effectiveness," UK government said in a statement.
Advertisement
20:08 IST, December 2nd 2020